The determination of blood transketolase before and serially after thiamine administration, and the response of clinical symptomatology after thiamine are reported in two normomagnesaemic patients and one hypomagnesaemic patient with acute Wernicke-Korsakoff encephalopathy. The response of the depressed blood transketolase and the clinical symptoms was retarded in the hypomagnesaemic patient. Correction of hypomagnesaemia was accompanied by the recovery of blood transketolase activity and total clearing of the ophthalmoplegia in this patient, suggesting that hypomagnesaemia may be a cause of the occasional thiamine refractoriness of these patients.
Previous studies have shown that the clinical entity of Wernicke-Korsakoff encephalopathy is related to an exclusive deficiency of thiamine (Phillips et al., 1952) . Furthermore, improvement in clinical symptoms, once the syndrome has developed, occurs only with the repletion of thiamine. It is this obvious and seemingly pure causal relationship of thiamine deficiency and Wernicke-Korsakoff encephalopathy that necessitates the total understanding of thiamine metabolism in the human if this disease is to be fully understood.
Both pyruvate decarboxylase and transketolase enzymes are thiamine pyrophosphate dependent (Horecker and Smyroniotis, 1953) . It has been shown, however, that in the central nervous system of rats deprived of thiamine, pyruvate decarboxylase activity is apparently refractory to thiamine depletion, whereas a rapid diminution of transketolase activity is earliest and most pronounced in the lateral vestibular nuclei of thiamine deficient rats (Dreyfus and Hauser, 1965) . If thiamine deprivation is prolonged, the initial decrease in transketolase activity is followed by stereotyped lesions in the lateral vestibular nuclei (Prickett, 1934; Dreyfus and Victor, 1961; Dreyfus, 1965) .
Blood transketolase activity is markedly reduced in patients with Wernicke-Korsakoff encephalopathy and serial assays in these patients usually reveal a rapid and essentially complete recovery of the reduced blood transketolase activity after the parental administration of thiamine (Brin, 1962; Dreyfus, 1962) . Because of the seemingly simultaneous recovery of enzyme activity and clinical improvement in the ophthalmoplegia, it has been hypothesized that the dysfunction of the transketolase enzyme system plays a role in the pathogenesis of Wernicke-Korsakoff encephalopathy.
Transketolase is an enzyme in the hexose monophosphate shunt which requires not only thiamine pyrophosphate but also magnesium as a co-factor. Wernicke-Korsakoff encephalopathy is a disease of the central nervous system in which there is considerable evidence that dysfunction of the transketolase enzyme system plays an aetiological role; however, the effect of hypomagnesaemia on the response to thiamine of transketolase enzyme activity and clinical symptomatology in patients with Wernicke-Korsakoff encephalopathy has never been investigated. Seven millilitres of blood were drawn from each patient and placed in heparinized tubes before and at four and 12 hours after administration of 100 mg thiamine intramuscularly. One 7 ml sample was also drawn at 36 hours from patient no. 3, who was hypomagnesaemic. This patient received a total of 6 g of MgSO4 intramuscularly in three divided doses over a 12 hour period beginning 14 hours after intramuscular thiamine was administered. All samples of heparinized blood were centrifuged immediately. The plasma was removed and a volume of distilled water equal to the packed erythrocyte volume was added to the erythrocytes to form a haemolysate. These were frozen and later used for determination of transketolase activity. Blood transketolase activity in six healthy normal subjects and in all experimental samples collected was determined by the method described by Brin (1966) . The buffer solution in this study contained no magnesium.
Haemolysate, 0.5 ml from each sample, was placed in two tubes. Tube 1 served as the blank and contained 0-65 ml of buffer. Tube 2 contained 0 45 ml of buffer and was incubated at 38°C for 30 minutes followed by the addition of 0-2 ml of a 7-0 mg/ml solution of sodium ribose-5-phosphate. This mixture was incubated for one hour at 38°C, followed by termination of the reaction by the addition to both tubes of 6-0 ml 7.50/ trichloracetic acid. The tubes were centrifuged at 3000 rpm for 10 minutes and 1 0 ml of the clear supernatant as well as 100 ug/ml and 50 ,ug/ ml D-glucose standards were used to determine spectrophotometrically the total hexose produced by the anthrone method described by Brin (1966) .
Transketolase activity was expressed in ,tg hexose per ml haemolysate per hour. (Table 2 ) The blood transketolase activity in the six normal subjects averaged 1070 Vg hexose/ml per hour. The blood transketolase activity of the three patients with Wernicke-Korsakoff encephalopathy before the administration of thiamine was markedly reduced. The response of the enzyme activity to parenteral thiamine was essentially complete in the normomagnesaemic patients 12 hours after intramuscular thiamine. Furthermore, the ophthalmoplegia described earlier in these patients was completely gone in 10 and six hours respectively after thiamine administration. In contrast, the response of blood transketolase activity and the ophthalmoplegia were retarded at 12 hours postthiamine administration in the hypomagnesaemic patient. The blood transketolase was 692 ,ug/ml and the left gaze palsy and right sixth nerve palsy were not improved at 12 hours. Not until the hypomagnesaemia was corrected in this patient by the administration of MgSO4 did the blood transketolase activity become normal and the ophthalmoplegia clear completely.
It is recognized that the small number of patients-and, in particular the fact that only one patient with hypomagnesaemia was studied -makes it difficult to draw firm conclusions from these observations. The different response of the hypomagnesaemic patient to thiamine and the apparent influence of added magnesium is sufficiently striking to warrant its presentation in support of a hypothesis that normal tissue magnesium is necessary for the thiamine response in patients with Wernicke-Korsakoff encephalopathy.
DISCUSSION
Experimental studies on the rat have shown that there is an interdependence between magnesium and thiamine in the body (Zieve et al., 1968a) . Transketolase activity in both the liver and blood of thiamine depleted hypomagnesaemic rats is markedly depressed and the recovery of the enzyme activity to thiamine is incomplete. Body growth is retarded in similar rats despite the administration of thiamine (Zieve et al., 1968a) . The mechanism by which magnesium deficiency interferes with the recovery of transketolase activity is not clear. Several hypotheses have been given. The simple unavailability of magnesium for the reaction has been considered unlikely, since the in vitro addition of magnesium at the time of transketolase assay does not increase activity (Zieve et al., 1968b) . Another hypothesis is that there is a lack of pentose substrate for the reaction, because of the magnesium requirement for substrate formation (Zieve et al., 1968b) .
In the two normomagnesaemic patients reported here there was complete improvement in ophthalmoplegia in 10 and six hours respectively and a manifest improvement 45 minutes after thiamine administration. The nystagmus became more pronounced as the ophthalmoplegia improved and ataxia and mental disturbances were much more refractory to therapy. In contrast, the hypomagnesaemic patient with WernickeKorsakoff encephalopathy showed no improvement of ophthalmoplegia 12 hours after thiamine. MgSO4 therapy was begun 14 hours after thiamine administration and the ophthalmoplegia subsequently reversed over the next 34 hours. Therefore, at least in these patients, clinical improvement seemed to have been correlated with the level of blood transketolase activity.
The presence of cirrhosis has been shown to be associated with a delayed response of both blood transketolase activity and lateral rectus palsy in patients with Wernicke-Korsakoff encephalopathy, presumably because of the inability to phosphorylate thiamine in hepatic disease (Cole et al., 1969) . Although hepatic enzymes were initially elevated in the three patients reported here, all enzymes became normal after three to six days of vitamins and diet. Only patient 1 had an elevated prothrombin time which reverted to normal four days after hospitalization. The physical examination of the hypomagnesaemic patient 3 revealed no evidence of hepatomegaly, ascites, spinal angiomata or dilated veins on the abdominal wall. Liver function tests done on the first hospital day demonstrated mild elevation of serum glutamic oxalacetic transaminase (110 mU/ml)* and lactate dehydrogenase (220 mU/ml) but normal alkaline phosphatase (65 mU/ml), total bilirubin (10 mg/100 ml), albumin (3*7 mg/ 100 ml) and prothrombin time (11.7 s; control 11 6 s). Liver function tests were normal on the third hospital day and throughout the rest of the hospital course. Cirrhosis, therefore, was an unlikely cause for the blood transketolase and ophthalmoplegia refractoriness occurring in this patient.
There is evidence suggesting that depressed activity of transketolase in the central nervous system is related aetiologically to the lesions produced by the deficiency of thiamine.
Furthermore, the demonstration of both trans4mU = milli-international units.
ketolase and clinical refractoriness to thiamine in the hypomagnesaemic patient, as well as improvement in symptoms and recovery of transketolase activity after the correction of hypomagnesaemia in this patient, supports the hypothesis that hypomagnesaemia is a cause of the thiamine refractoriness that is seen occasionally in patients with acute Wernicke-Korsakoff encephalopathy.
